Reduction of DNA Topoisomerase Top2 Reprograms the Epigenetic Landscape and Extends Health and Life Span Across Species
Aging Cell · 2025
DOI: 10.1111/acel.70010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, 2025. Verfasst von Man Zhu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Management & Institute of Health Management, Sichuan Provincial People's Hospital, University of Electronic Science and Technolo…. Hauptthemen laut MEDLINE: Longevity, DNA Topoisomerases, Type II, Epigenesis, Genetic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sichuan Province Science and Technology Support Program, University of Electronic Science and Technology of China and China West Hospital, Sichuan Provincial Science and Technology Support Program.
Abstract (Originalsprache)
DNA topoisomerases are essential molecular machines that manage DNA topology in the cell and play important roles in DNA replication and transcription. We found that knocking down the enzyme topoisomerase Top2 or its mammalian homolog TOP2B increases the lifespan of S. cerevisiae , C. elegans , and mice. TOP2B reduction also extends the health span of mice and alleviates the pathologies of aging in multiple tissues. At the cellular/molecular level, TOP2B reduction alleviates the major hallmarks of aging, including senescence, DNA damage, and deregulated nutrient sensing. We observed that TOP2B reduction changes the epigenetic landscape of various tissues in old mice toward that of the young animals, and differentially downregulates genes with active promoter and high expression. Our observations suggest that Top2 reduction confers pro‐longevity effect across species possibly through a conserved mechanism and may be a promising strategy for longevity intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health Management & Institute of Health Management, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
- Laboratory of Aging Research, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
- Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, California, USA.
ORCID-Profile: Man Zhu
Förderung
- Sichuan Province Science and Technology Support Program
- University of Electronic Science and Technology of China and China West Hospital
- Sichuan Provincial Science and Technology Support Program
Zitieren
APA
Zhu, M., Ma, M., Luo, L., Li, F., Zheng, J., Pan, Y., Yang, L., Xiao, Y., Wang, Z., Xian, B., Zheng, Y., Li, H., & Yang, J. (2025). Reduction of DNA Topoisomerase Top2 Reprograms the Epigenetic Landscape and Extends Health and Life Span Across Species. Aging Cell. https://doi.org/10.1111/acel.70010
Vancouver
Zhu M, Ma M, Luo L, Li F, Zheng J, Pan Y, et al. Reduction of DNA Topoisomerase Top2 Reprograms the Epigenetic Landscape and Extends Health and Life Span Across Species. Aging Cell. 2025. doi:10.1111/acel.70010
BibTeX
@article{Zhu2025,
author = {Zhu, Man and Ma, Meng and Luo, Lunan and Li, Feiyang and Zheng, Jiashun and Pan, Yan and Yang, Lu and Xiao, Ying and Wang, Ziyan and Xian, Bo and Zheng, Yi and Li, Hao and Yang, Jing},
title = {Reduction of DNA Topoisomerase Top2 Reprograms the Epigenetic Landscape and Extends Health and Life Span Across Species},
journal = {Aging Cell},
year = {2025},
doi = {10.1111/acel.70010}
}
EUVIMED